EA202091627A1 - COMPOUNDS AND METHODS OF TRANSMEMBRANE DELIVERY OF MOLECULES - Google Patents

COMPOUNDS AND METHODS OF TRANSMEMBRANE DELIVERY OF MOLECULES

Info

Publication number
EA202091627A1
EA202091627A1 EA202091627A EA202091627A EA202091627A1 EA 202091627 A1 EA202091627 A1 EA 202091627A1 EA 202091627 A EA202091627 A EA 202091627A EA 202091627 A EA202091627 A EA 202091627A EA 202091627 A1 EA202091627 A1 EA 202091627A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
compounds
delivery system
molecules
vivo
Prior art date
Application number
EA202091627A
Other languages
Russian (ru)
Inventor
Илан Цив
Хадит Гримберг
Йозеф Дубровски
Original Assignee
Апосенс Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Апосенс Лтд. filed Critical Апосенс Лтд.
Priority claimed from PCT/IL2018/051416 external-priority patent/WO2019130319A1/en
Publication of EA202091627A1 publication Critical patent/EA202091627A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В данном изобретении предложена новая система доставки для доставки лекарственных соединений через биологические мембраны. Предложены новые химические конъюгаты, которые содержат указанную систему доставки, способы синтеза указанных соединений и способы применения указанной системы доставки, среди прочего, для доставки генетических лекарственных соединений в ткани и клетки, in vitro, ex vivo и in vivo, для лечения различных заболеваний.The present invention provides a novel delivery system for delivering drug compounds across biological membranes. New chemical conjugates are proposed that contain the specified delivery system, methods for the synthesis of these compounds and methods of using the specified delivery system, inter alia, for the delivery of genetic drugs to tissues and cells, in vitro, ex vivo and in vivo, for the treatment of various diseases.

EA202091627A 2018-07-04 2018-12-31 COMPOUNDS AND METHODS OF TRANSMEMBRANE DELIVERY OF MOLECULES EA202091627A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862693922P 2018-07-04 2018-07-04
PCT/IL2018/051416 WO2019130319A1 (en) 2018-01-01 2018-12-31 Compounds and methods for trans-membrane delivery of molecules

Publications (1)

Publication Number Publication Date
EA202091627A1 true EA202091627A1 (en) 2020-11-25

Family

ID=73649869

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091627A EA202091627A1 (en) 2018-07-04 2018-12-31 COMPOUNDS AND METHODS OF TRANSMEMBRANE DELIVERY OF MOLECULES

Country Status (1)

Country Link
EA (1) EA202091627A1 (en)

Similar Documents

Publication Publication Date Title
MX2018002099A (en) Compounds and methods for trans-membrane delivery of molecules.
Sareddy et al. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
EA202191313A1 (en) COMPOSITIONS BASED ON LIPID NANOPARTICLES
MX2016012716A (en) Compounds and methods for trans-membrane delivery of molecules.
CY1123625T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDERS, PAIN AND OTHER DISEASES
Wium et al. The role of the receptor tyrosine kinase Axl in carcinogenesis and development of therapeutic resistance: An overview of molecular mechanisms and future applications
WO2008103409A3 (en) Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
PE20191152A1 (en) ANTIBODIES AND POLYPEPTIDES TARGETED AGAINST CD127
EA201200002A1 (en) INDOLAMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
PE20081653A1 (en) USE OF SPECIFIC BINDING MOLECULES TO THE CD20 ANTIGEN IN A SINGLE DOSE
CY1117326T1 (en) CATEGOLAMINE PRODUCT USEFUL FOR PARKINSON'S DISEASE TREATMENT
Iglesia et al. Heat shock proteins in glioblastoma biology: where do we stand?
CY1118073T1 (en) COMPOSITIONS AND METHODS FOR INCREASING THE TELECOMMUNICATION ACT
EA201991661A1 (en) COMPOUNDS AND METHODS OF TRANSMEMBRANE DELIVERY OF MOLECULES
MX2018006299A (en) Peptide analogs of alpha-melanocyte stimulating hormone.
EA202091203A1 (en) LIGAND-DRUG CONJUGATES AS SUBSTRATES FOR SELECTIVE DECOMPOSITION UNDER THE ACTION OF EXOPEPTIDASE ACTIVITY OF CATEPSIN B
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
EA201101674A1 (en) 2,4-DIAMINOPYRIMIDINES INTRODUCED FOR THE TREATMENT OF DISEASES DETERMINED BY EXCESS OR ANOMALOUS CELLULATION
MX2019005671A (en) Substances for targeting various selected organs or tissues.
WO2018071741A8 (en) Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
BR112015003836A2 (en) drug delivery systems and methods for bladder cancer treatment
EA201200604A1 (en) PHARMACEUTICAL SUBSTANCES ON THE BASIS OF MITOCHONDRIAL ADDRESSED ANTIOXIDANTS
US20240026357A1 (en) Modified mir-135, conjugated form thereof, and uses of same
WO2010034016A3 (en) Diaphragm drug pump
EA201690004A1 (en) ANTIBODIES AGAINST LAMP1 AND CONJUGATES ANTIBODIES AND MEDICINES AND THEIR APPLICATION